References

1. Polsky B, Gold JWM, Whimbey E, et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104:38-41.

2. Whimbey E, Gold JWM, Polsky B, et al. Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. Ann Int Med 1986; 104:511-4.

3. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987; 82:900-6.

4. Farizo KM, Buehler JW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992; 267:1798-805.

5. Munoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. Am J Epidemiol 1993; 137:423-38.

6. Stein M, O'Sullivan P, Wachtel T, et al. Causes of death in persons with human immunodeficiency virus infection. Am J Med 1992; 93:387-90.

7. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327:1697-703.

8. Selwyn P, Feingold A, Hartel D, et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988; 2:267-72.

9. Bandres JC, Trial J, Musher DM, Rossen RD. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J Infect Dis 1993; 168: 75-83.

10. Gabrilovich DI, Vassilev V, Nosikov VV, Serebrovskaya LV, Ivanova LA, Pokrovsky VV. Clinical significance of HIV DNA in polymorphonuclear neutrophils from patients with HIV infection. J AIDS 1993; 6:587-91.

11. Pitrak DL, Bak PM, DeMarais P, Novak RM, Andersen BR. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis 1993; 167:1406-10.

12. Gabrilovich D, Ivanova L, Serebrovskaya L, Shepeleva G, Pobrovsky V. Clinical significance of neutrophil functional activity in HIV infection. Scand J Infect Dis 1994; 26:41-7.

13. Jones G, Watret KC, Bjerknes R, Bird AG, Leen CL, Brettle RP. Impaired neutrophil function in patients with HIV [Po-B06-1104]. In: 9th International Conference on AIDS, Berlin, June 6-11, 1993.

14. Vanacore R, Carulli G, Paladini A, Sbrana S, Ceretelli S, Ambrogi F. Reduced expression of Fcg RIII (CD16) on neutrophils from HIV infected subjects in different phase of disease. In: 9th International Conference on AIDS, Berlin, June 6-11, 1993.

15. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309:453-8.

16. Scott ME, Landay AL, Lint TF, Spear GT. In vive decrease in the expression of complement receptor 2 on B cells in HIV infection. AIDS 1993; 7:37-41.

17. Davis L, Beck JM, Shellito J. Update: HIV infection and pulmonary host defenses. Sem Resp Infect 1993; 8:75-85.

18. Montagnier L, Blanchard A. Mycoplasma as cofactors in infection due to the human immunodeficiency virus. Clin Inf Dis 1993; 17(suppl 1):S309-315.

19. Behbahani N, Blanchard A, Cassell GH, Montagnier L. Phylogenetic analysis of Mycoplasma penetrans, isolated from HIV-infected patients. Fems Microbiol Lett 1993; 109:63-6.

20. Dawson MS, Hayes MM, Wang RY, Armstrong D, Kundsin RB, Lo SC. Detection and isolation of Mycoplasma fermentans from urine of human immunodeficiency virus type 1-infected patients. Arch Pathol Lab Med 1993; 117: 511-4.

21. Lo SC, Wang R, Weiss SH, Grandinetti T, Alter H, Shih J. Mycoplasma penetrans infection associated with Kaposi's sarcoma in male homosexuals with AIDS. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

22. Tully JG, Shih JW, Wang RH, Rose DL, Lo SC. Titers of antibody to Mycoplasma in sera of patients infected with human immunodeficiency virus. Clin Infect Dis 1993; 17(suppl 1):S254-8.

23. Wang RY, Shih JW, Grandinetti T, et al. High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet 1992; 340:1312-6.

24. Wang RY, Shih JW, Weiss SH, et al. Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis 1993; 17:724-9.

25. Wang R, Grandinetti T, Melcher G, et al. Seroconversion following Mycoplasma penetrans infection in patients with AIDS. Abstr Gen Meet Am Soc Microbiol 1993; 93:165.

26. Grau O, Slizewicz B, Tuppin P, et al. Association of Mycoplasma penetrans with HIV infection. In: 10th International Conference on AIDS, Yokohama, Japan, August 7-11, 1994.

27. Grau O, Tuppin P, Slizewicz B, et al. Seroprevalence of M. penetrans in HIV-positive and H1V-negative individuals in Brazzaville (Congo). In: 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994.

28. Greenberg AE, Thomas PA, Landesman SH, et al. The spectrum of HIV-1-related disease among outpatients in New York City. AIDS 1992; 6:849-59.

29. Mientjes GH, van Ameijden EJ, van den Hoek AJ, Coutinho RA. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. AIDS 1992; 6:207-12.

30. Wallace JM, Rao AV, Glassroth J, et al. Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Resp Dis 1993; 148:1523-9.

31. Manfredi R, Costigliola P, Ricchi E, Chiodo F. Sepsis-bacteremia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection. Clin Terapeut 1993; 143: 279-90.

32. Keiser P, Higgs E, Peterson D. Neutropenia is associated with bacterial infections [Abstract PB0574]. In: 10th International Conference on AIDS, Yokahama, Japan, 1994.

33. Arzuaga J, Moreno S, Miralles P, Cosin J, et al. Lower respiratory tract infections in HIV-infected patients. In: 10th International Conference on AIDS, Yokohama, Japan, 1994.

34. Chidiac C, Alfandari S, Senneville E, Lecocq P, Ajana F, Mouton Y. Bacterial lower respiratory tract infections (BLRTI) in patients with HIV infection (PWH): the experience of CISIH 18(north France AIDS reference center). In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

35. Schwartzman WA, Patnaik M, Angula FJ, Visscher BR, Miller EN, Peter JB. Nested case-control study of Rochalimaea antibodies, dementia, and cat ownership in HIV-infected men [Abstract #373]. Orlando, FL: 1994.

36. Furman A, Sepkowitz KA, Jacobs J. Pulmonary cavity in AIDS: Etiology, clinical presentation and outcome. In: 9th International Conference on AIDS, Berlin, June 6-11, 1993.

37. Hardalo C, Khoshnood K, Alcabes P, Freidland GH. High incidence and recurrence rates of bacterial endocarditis in HIV+ drug injectors (Abstract #336B]. In: 10th International Conference on AIDS, Yokohama, Japan, 1994.

38. Falco V, Fernandez-de-Sevella T, Alegre J, et al. Bacterial pneumonia in HIV-infected patients: a prospective study of 68 episodes. Eur Resp J 1994; 7:235-9.

39. Caiaffa WT, Vlahov D, Graham NM, Solomon L, Nelson KE, Munoz A. Risk factors for bacterial pneumonia among HIV seropositive (HIV+) intravenous drug users (IDUs) [Abstract PO-C15-2930]. In: 9th International Conference on AIDS, Berlin, June 6-11, 1993.

40. Baron AD, Hollander H. Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Resp Dis 1993; 148:992-6.

41. Fichtenbaum CJ, Woeltje KF, Powderly WG. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 1994; 19:417-22.

42. Nelson MR, Shanson DC, Barter GJ, Hawkins DA, Gazzard BG. Pseudomonas septicemia associated with HIV. AIDS 1991; 5:761-3.

43. Kielhofner M, Atmar RL, Hamill RJ, Musher DM. Life threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis 1992; 14:403-11.

44. Franzetti F, Cernuschi M, Esposito R, Moroni M. Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med 1992; 231: 437-43.

45. Dropulic LK, Eldred L, Leslie J, Yamaguchi E, Chaisson R, Sears CL. Pseudomonas aeruginosa infections in HIV-positive patients [Abstract WS-BO8-5]. In: 9th International Conference on AIDS. Berlin, June 4-11, 1993.

46. Schuster MG, Norris AH. Pseudomonas infection in patients with HIV infection [Abstract #33]. In: 32nd Annual Meeting of the Infectious Diseases Society of America, Orlando, FL, October 7-9, 1994.

47. Uttamchandani RB, Daikos GL, Reyes RR, et al. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis 1994; 18:348-53.

48. Vestbo J, Lundgren JD, Gaub J, Rder B, Gutschik E. Severe Rhodococcus equi pneumonia: case report and literature review. Eur J Clin Microbiol Infect Dis 1991; 10:762-8.

49. Verville TD, Huycke MM, Greenfield RA, Fine DP, Kuhls TL, Slater LN. Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine 1994; 73:119-32.

50. Drancourt M, Bonnet E, Gallais H, Peloux Y, Raoult D. Rhodococcus equi infection in patients with AIDS. J Infect 1992; 24:123-31.

51. Harvey RL, Sunstrum JC. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis 1991; 13: 139-45.

52. Emmons W, Reichwein B, Winslow DL. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case. Rev Infect Dis 1991; 13:91-6.

53. Mastroianni CM, Vullo V, Delia S. Rhodococcus equi infection in AIDS patients: Protective role of humoral immunity [Abstract PB0556]. In: 10th International Conference on AIDS, Yokohama, August 7-12, 1994.

54. Martos A, Podzamczer D, Concejo C, Martinez R, Verdejo J, Alcaide F. Nocardial infection in HIV-infected patients. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

55. Kramer MR, Uttamachandani RB. The radiographic appearance of pulmonary nocardiosis associated with AIDS. Chest 1990; 98:382-5.

56. Sullivan JF, Benson CA, Sha BE. Bordetella bronchiseptica infections in patients; with AIDS [Abstract 273]. In: 32nd Annual Meeting of the Infectious Diseases Society of America, Orlando, FL, October 7-9, 1994.

57. Visco CU, Farinelli S, Ferone U, Mascellino MT, Mastroianni CM, Sorice F. Bacterial septicemia in HIV patients in Rome. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

58. Garcia P, Bermudez C, Gaynes R, Bisno AL. Bacteremia in persons infected with HIV: epidemiology and the possible value of PCP prophylaxis [Abstract #282]. In: 32nd Annual Meeting of the Infectious Diseases Society of America, Orlando, FL, October 7-9, 1994.

59. Tumbarello M, Tacconelli E, Del FA, Federico G, Cauda R. Central venous catheter-related sepsis in HIV infected patients. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

60. Stanley HD, Charlebois E, Harb G, Jacobson MA. Central venous catheter infections in AIDS patients. J AIDS 1994; 7:272-8.

61. Matz K, Emmerling P, Loch O, Machler G, Emminger C. Bacteremia in HIV- patients with ARC and AIDS. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

62. Carey J, Hart C, Stoeckle M. High incidence of gram-negative catheter-associated bacteremia in HIV+ patients. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

63. Hirschhorn LR, Steger KA, Adair V, Heeren T, Webster B, Craven DE. A double-blind, placebo-controlled trial of mupirocin (MUP) for eradication of Staphylococcal aureus (SA) colonization in HIV-infected patients [Abstract #193]. In: 32nd Annual Meeting of the Infectious Diseases Society of America Meeting, Orlando, FL, October 7-9, 1994.

64. Manoff SB, Vlahov D, Herskowitz A, Cohn S, Munoz A, Nelson KE. HIV infection and endocarditis among injection drug users (IDUs). In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

65. Valencia ME, Guinea J, Moreno V, Martinet ML, Gazapo E, Gonzalez LJ. Infective endocarditis in IVDA in Spain: a comparison of HIV negative and positive patients. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

66. Pulvirenti J, Kerns L, Benson C, Lisowski J, Demarais P. Endocarditis (IE) in injectable drug users (IDU): a retrospective evaluation based on HIV serostatus and degree of immunosuppression [Abstract #30). In: 32nd Annual Meeting of the Infectious Diseases Society of America. Orlando, FL, October 7-9, 1994.

67. Loutit JS, Tompkins LS. Bacillary angiomatosis. In: Broder SA, Merigan TC, Bolognesi D, eds. Textbook of AIDS medicine. Baltimore: William Wilkins, 1994:301-10.

68. Cotell SL, Noskin GA. Bacillary angiomatosis. Clinical and histologic features, diagnosis, and treatment. Arch Int Med 1994; 154:524-8.

69. Koehler JE, Glaser CA, Tappero JW. Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir. JAMA 1994; 271:531-5.

70. Berger TG, Koehler JE. Bacillary angiomatosis. In: Sande M, Volberding P, eds. AIDS clinical review. New York: Marcel Dekker, 1993:43-60.

71. Koehler JE, Tappero JW. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1993; 17:612-24.

72. Slater LN, Welch DF, Min KW. Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Int Med 1992; 152:602-6.

73. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N Engl J Med 1990; 323:1573-80.

74. Koehler JE, Quinn FD, Berger TG, LeBoit PE, Tappero JW. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625-31.

75. Tappero JW, Mohle BJ, Koehler JE, et al. The epidemiology of bacillary angiomatosis and bacillary peliosis. JAMA 1993; 269:770-5.

76. Childs JE, Rooney JA, Cooper JL, Olson JG, Regnery RL. Epidemiologic observations on infection with Rochalimaea species among cats living in Baltimore, Md. J Am Vet Med Assoc 1994; 204:1775-8.

77. Guerra LG, Neira CJ, Boman D, et al. Rapid response of AIDS-related bacillary angiomatosis to azithromycin. Clin Infect Dis 1993; 17:264-6.

78. Schwartzman WA, Reddy M, Patnaik M. "Aseptic" meningitis in HIV caused by Rochalimaea henselae. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

79. Schwartzman WA, Patnaik M, Barka NE, Peter JB. Rochalimaea antibodies in HIV-associated neurologic disease. Neurology 1994; 44:1312-6.

80. Patnaik M, Schwartzman WA, Barka NE, Peter JB. Possible role of Rochalimaea henselae in the pathogenesis of AIDS encephalopathy [letter; comment]. Lancet 1992; 340:9710.

81. Sevall JS, Mam V, Patnaik M, Peter JB, Schwartzman WA. PCR detection of Rochalimaea henselae DNA in cerebrospinal fluid. In: 9th International Conference on AIDS, Berlin, June 4-11, 1993.

82. Small CB, Kaufman A, Armenaka M, Rosenstreich DL. Sinusitis and atopy in human immunodeficiency virus infection. J Infect Dis 1993; 167:283-90.

83. Thompson C, Salvato P, Stroud S, Hasheeve D. Etiology of acute sinusitis in HIV infection [Abstract # WS-B08-6]. In: 9th International Conference on AIDS, Berlin, Germany, June 6-11, 1993; 9:51.

84. von Schoennberg MA, Grant AD, Grant HR, Miller RF. Paranasal sinus disease in HIV antibody positive patients [Abstract PO-B06-1106]. In: 9th International Conference on AIDS, Berlin, June 6-11, 1993.

85. Pneumococcal polysaccharide vaccine. MMWR 1989; 38:64-68, 73-76.

86. LeBoit PE, Berger TG, Egbert BM, Beckstead JH, Yen TS, Stoler MH. Bacillary angiomatosis. The histopathology and differential diagnosis of a pseudoneoplastic infection in patients with human immunodeficiency virus disease. Am J Surg Pathol 1989; 13:909-20.

87. Glaser JB, Volpe S, Aguirre A, Simpkins H, Schiffman G. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 1991; 164:761-4.

88. Janoff EN, Douglas JMJ, Gabriel M, et al. Pneumococcal polysaccharide vaccine. MMWR 1989; 38:64-8.

89. Huang KL, Ruben FL, Rinaldo CRJ, Kingsley L, Lyter DW, Ho M. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis 1988; 158:983-90.

90. Kroon FP, van Dissel JT, deJong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4 + lymphocytes. AIDS 1994; 8:469-76.

91. Cimoch PJ, Loss SD, Houghton RA, et al. Antibody response to pneumococcal vaccination in HIV-I infected patients. In: 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994.

92. Steinhoff M, Ahmed F, Rodriguez-Barradas M, Nelson K, Hamilton R, Musher D. Antibody response to a new protein-conjugated pneumococcal vaccine in HIV-infected adults [Abstract #242]. In: 32nd Annual Meeting of the Infectious Diseases Society of America Annual Meeting, Orlando, FL, October 7-9, 1994.

93. Demaurex N, Gabriel V, Auckenthaler R, Demaurex F, Hirschel B. The efficacy of pneumococcal vaccination in HIV seropositive patients (HIV +): a case-control study. In: 8th International Conference on AIDS, Amsterdam, July 19-24, 1992.

94. Wortley P, Farizo K, Chu S. Pneumococcal and influenza vaccination levels among HIV-infected adolescents and adults receiving medical care in the United States. AIDS 1994; 8:941-944.

95. Hardy WD, Feinberg J, Finkelstein DM, et al. A controlled trial of trimethoprim-sulfamethoxazole or pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency virus (AIDS Clinical Trials Group Protocol 021). N Engl J Med 1992; 327: 95-9.

96. Mayer HB, Rose DN, Cohen S, Gurtman AC, Cheung TW, Szabo S. The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients [letter]. AIDS 1993;7:1687-9.

97. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271:1831-5.

98. de la Rubia F, Clavo A, Lopez Prieto D, de la Cueto M, et al. Antimicrobial susceptibility of Streptococcus pneumoniae in HIV patients (Abstract PB0568). in: 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994.

99. Mofenson LM, Moye J, Bethel J, et al. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4 counts of 0.20 x 10⁹/1 or more: effect on viral, opportunistic, and bacterial infections. JAMA 1992; 268:483-8.

100. Mars ME, Quinson AM, North MO, Gallais H. Contribution of intravenous immunoglobulins (IVIG) therapy in HIV infected adults. In: 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994.

101. Kiehl M, Heese C, Stoll R, Domschke W. Treatment of HIV infected adult patients with high-dose intravenous immunoglobulin. A randomized trial. In: 10th International Conference on AIDS, Yokohama, Japan, August 7-12, 1994.

102. Yap FL. Does intravenous immune globulin have a role in HIV-infected patients? Clin Exp Immunol 1994; 1:59-67.